PATENT CLAIM ANALYSIS

Application Number: 15768001
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "651000"]

Abstract:
The present invention relates to the field of myocardial infraction (MI). It more specifically relates to an agent stimulating, either directly or indirectly, the 5-hydroxytryptamine 1B receptor, and to a composition comprising said agent, for use in the treatment of a patient having a myocardial infraction (MI). The invention further encompasses therapeutic and screening methods.

Claim (Index 10):
The composition for use according to  claim 9 , further comprising at least one active agent.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 91.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15744345', '15548555', '15106286', '13757944', '11667899']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6785026564936592
- 35 USC 102 Novelty (BERT): 0.5268538327402169
- Combined Prediction Score: 0.663337774118315
- Mean Citation Score: 175.44384800000003
- Max Citation Score: 301.73428
- Similarity Product: 198.6737556071687

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test